Whan In PharmLtd Dividends and Buybacks
Dividend criteria checks 2/6
Whan In PharmLtd is a dividend paying company with a current yield of 2.46% that is well covered by earnings. Next payment date is on 17th April, 2025 with an ex-dividend date of 27th December, 2024.
Key information
2.5%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 2.5% |
| Dividend Growth | 4.5% |
| Next dividend pay date | 17 Apr 25 |
| Ex dividend date | 27 Dec 24 |
| Dividend per share | ₩300.000 |
| Payout ratio | 17% |
Recent dividend and buyback updates
Recent updates
Did Whan In Pharm Co.,Ltd. (KRX:016580) Use Debt To Deliver Its ROE Of 7.8%?
Mar 15
Here's Why I Think Whan In PharmLtd (KRX:016580) Might Deserve Your Attention Today
Feb 25Whan In Pharm Co.,Ltd.'s (KRX:016580) 1.6% Dividend Yield Looks Pretty Interesting
Feb 04
What Is The Ownership Structure Like For Whan In Pharm Co.,Ltd. (KRX:016580)?
Jan 14Why You Might Be Interested In Whan In Pharm Co.,Ltd. (KRX:016580) For Its Upcoming Dividend
Dec 24Does Whan In Pharm Co.,Ltd. (KRX:016580) Create Value For Shareholders?
Dec 11Whan In PharmLtd's (KRX:016580) Shareholders Are Down 33% On Their Shares
Nov 20Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, A016580 has been paying a dividend for less than 10 years.
Growing Dividend: A016580 has only been paying a dividend for 5 years, and since then payments have not increased.
Dividend Yield vs Market
| Whan In PharmLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A016580) | 2.5% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 3.9% |
| Industry Average (Pharmaceuticals) | 1.0% |
| Analyst forecast (A016580) (up to 3 years) | 2.5% |
Notable Dividend: A016580's dividend (2.46%) is higher than the bottom 25% of dividend payers in the KR market (1.18%).
High Dividend: A016580's dividend (2.46%) is low compared to the top 25% of dividend payers in the KR market (3.94%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (16.7%), A016580's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: A016580 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 22:19 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Whan In Pharm Co.,Ltd. is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hyung Soo Kim | Hanwha Investment & Securities Co., Ltd. |
| Jonathan Rhee | Hyundai Motor Securities Co. Ltd. |
| Seung-Ho Lee | iM Securities |